======= SEL1L ======= == Gene Information == * **Official Symbol**: SEL1L * **Official Name**: SEL1L adaptor subunit of ERAD E3 ubiquitin ligase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6400|6400]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBV2|Q9UBV2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SEL1L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SEL1L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602329|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is part of a protein complex required for the retrotranslocation or dislocation of misfolded proteins from the endoplasmic reticulum lumen to the cytosol, where they are degraded by the proteasome in a ubiquitin-dependent manner. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]. * **UniProt Summary**: Plays a role in the endoplasmic reticulum quality control (ERQC) system also called ER-associated degradation (ERAD) involved in ubiquitin-dependent degradation of misfolded endoplasmic reticulum proteins (PubMed:16186509). Enhances SYVN1 stability. Plays a role in LPL maturation and secretion. Required for normal differentiation of the pancreas epithelium, and for normal exocrine function and survival of pancreatic cells. May play a role in Notch signaling. {ECO:0000250|UniProtKB:Q9Z2G6, ECO:0000269|PubMed:16186509}. |fn2| |Sel1| |Hrd1p ubiquitin ligase complex| |Hrd1p ubiquitin ligase ERAD-L complex| |Derlin-1 retrotranslocation complex| |endoplasmic reticulum mannose trimming| |endoplasmic reticulum to cytosol transport| |retrograde protein transport, ER to cytosol| |protein alpha-1,2-demannosylation| |protein demannosylation| |endoplasmic reticulum quality control compartment| |protein exit from endoplasmic reticulum| |protein deglycosylation| |ubiquitin-dependent ERAD pathway| |triglyceride metabolic process| |ERAD pathway| |acylglycerol metabolic process| |neutral lipid metabolic process| |Notch signaling pathway| |protein secretion| |establishment of protein localization to extracellular region| |protein localization to extracellular region| |peptide secretion| |protein stabilization| |ubiquitin-protein transferase activity| |response to endoplasmic reticulum stress| |regulation of protein stability| |proteasome-mediated ubiquitin-dependent protein catabolic process| |proteasomal protein catabolic process| |glycerolipid metabolic process| |glycoprotein metabolic process| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |cellular macromolecule catabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |intracellular protein transport| |response to organonitrogen compound| |secretion by cell| |endoplasmic reticulum| |carbohydrate derivative metabolic process| |export from cell| |macromolecule catabolic process| |organonitrogen compound catabolic process| |response to nitrogen compound| |secretion| |lipid metabolic process| |proteolysis| |transmembrane transport| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |cellular response to stress| |organic substance catabolic process| |cellular catabolic process| |establishment of localization in cell| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp513|ONC212 0.15μM R08 exp513]]|-2.8| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-1.76| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|1.77| |[[:results:exp187|proTAME 5μM R04 exp187]]|1.77| |[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|1.78| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|1.84| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|1.89| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|1.92| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.94| |[[:results:exp405|Tenofovir 10μM R07 exp405]]|1.94| |[[:results:exp246|UM0011500 10μM R05 exp246]]|2.13| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|2.14| ^Gene^Correlation^ |[[:human genes:t:tbc1d3h|TBC1D3H]]|0.485| |[[:human genes:d:ddtl|DDTL]]|0.479| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.476| |[[:human genes:t:tbc1d3g|TBC1D3G]]|0.475| |[[:human genes:z:zfand5|ZFAND5]]|0.468| |[[:human genes:t:tbc1d3c|TBC1D3C]]|0.468| |[[:human genes:t:tbc1d3f|TBC1D3F]]|0.454| |[[:human genes:d:dnttip2|DNTTIP2]]|0.453| |[[:human genes:p:psmd3|PSMD3]]|0.449| |[[:human genes:p:psmb2|PSMB2]]|0.449| |[[:human genes:s:sec13|SEC13]]|0.448| |[[:human genes:a:atp13a1|ATP13A1]]|0.444| |[[:human genes:d:dock6|DOCK6]]|0.437| |[[:human genes:s:syt9|SYT9]]|0.437| |[[:human genes:w:wdr43|WDR43]]|0.433| |[[:human genes:c:c1qtnf9b|C1QTNF9B]]|0.433| |[[:human genes:t:tbc1d3|TBC1D3]]|0.43| |[[:human genes:s:smg7|SMG7]]|0.429| |[[:human genes:t:tceb3cl|TCEB3CL]]|0.428| |[[:human genes:t:tbc1d3i|TBC1D3I]]|0.427| |[[:human genes:t:tbc1d3e|TBC1D3E]]|0.427| |[[:human genes:t:tbc1d3k|TBC1D3K]]|0.426| |[[:human genes:t:tbc1d3l|TBC1D3L]]|0.426| |[[:human genes:m:med17|MED17]]|0.425| |[[:human genes:p:polr2j3|POLR2J3]]|0.423| |[[:human genes:c:ccdc94|CCDC94]]|0.42| |[[:human genes:s:slc4a1|SLC4A1]]|0.419| |[[:human genes:t:tfip11|TFIP11]]|0.419| |[[:human genes:r:rrn3|RRN3]]|0.418| |[[:human genes:c:cope|COPE]]|0.414| |[[:human genes:p:psmd1|PSMD1]]|0.414| |[[:human genes:r:rfxank|RFXANK]]|0.413| |[[:human genes:c:casc3|CASC3]]|0.412| |[[:human genes:c:cdc45|CDC45]]|0.412| |[[:human genes:r:rps14|RPS14]]|0.41| |[[:human genes:a:akirin2|AKIRIN2]]|0.409| |[[:human genes:t:tceb3c|TCEB3C]]|0.408| |[[:human genes:o:orc1|ORC1]]|0.407| |[[:human genes:s:smg1|SMG1]]|0.403| |[[:human genes:n:ndc1|NDC1]]|0.403| |[[:human genes:f:fcn2|FCN2]]|0.401| |[[:human genes:m:mt1e|MT1E]]|0.401| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 807 * **Expression level (log2 read counts)**: 7.74 {{:chemogenomics:nalm6 dist.png?nolink |}}